In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
New 2013 ESC Guidelines on stable coronary artery disease
Session

Event : ESC Congress 2013

Topic : Coronary Artery Disease (Chronic)

  • Session type : Symposium
  • Date : 01 September 2013
  • Time : 16:30 - 18:00

4 presentations in this session

Stable coronary artery disease beyond flow-limiting stenoses.

Event : ESC Congress 2013

  • Session : New 2013 ESC Guidelines on stable coronary artery disease
  • Speaker : F Crea (Roma,IT)

Diagnosis and prognosis of stable coronary artery disease.

Event : ESC Congress 2013

  • Session : New 2013 ESC Guidelines on stable coronary artery disease
  • Speaker : S Achenbach (Erlangen,DE)

Drugs in stable coronary artery disease.

Event : ESC Congress 2013

  • Session : New 2013 ESC Guidelines on stable coronary artery disease
  • Speaker : J Hulot (Paris,FR)

From optimal medical therapy to revascularisation.

Event : ESC Congress 2013

  • Session : New 2013 ESC Guidelines on stable coronary artery disease
  • Speaker : B Gersh (Rochester,US)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are